Given that lipidation of apoE is favored when the protein is in its monomeric form [84], it is possible that the reduced hydrophobicity and/or conformational change in apoE3 caused by the V236E substitution results in its reduced oligomerization and increased lipidation capacity, contributing to its protective role in AD. The gene discussed is APOE; the disease is Alzheimer disease.